TiHo Bibliothek elib - Tierärztliche Hochschule Hannover

LITERATURVERZEICHNIS
FRICKER, G., MILLER, D.S., 2004. Modulation of drug transporters at the blood-brain barrier.
Pharmacology 70: 169–176.
FROMM, M.F., 2004. Importance of P-glycoprotein at blood–tissue barriers. Trends Pharmacol. Sci.
25: 423–429.
FROMM, M.F., KAUFFMANN, H.M., FRITZ, P,. BURK, O., KROEMER, H.K., WARZOK, R.W.,
EICHELBAUM, M., SIEGMUND, W., SCHRENK, D., 2000. The effect of rifampin treatment on
intestinal expression of human MRP transporters. Am J Pathol 157: 1575–1580.
FU, D., ARIAS, I.M., 2012. Intracellular trafficking of P-glycoprotein. Int J Biochem Cell Biol. 44: 461-4.
FU, D., BEBAWY, M., KABLE, E., ROUFOGALIS, B.D., 2004. Subcellular localization of P-
glycoprotein-EGFP fusion protein: implication in multidrug resistance in cancer. Int. J Cancer.
109: 174–181.
FU, D., VAN DAM, E., BRYMORA, A., DUGGIN, I.G., ROBINSON, P.J., ROUFOGALIS, B.D., 2007.
The small GTPases Rab5 and RalA regulate intracellular traffic of P-glycoprotein. Biochim
Biophys Acta. 1773: 1062-72.
GAILLARD, P.J., DE BOER, A.G., 2000. Relationship between permeability status of the blood-brain
barrier and in vitro permeability coefficient of a drug. Eur J Pharm Sci. 12: 95-102.
GAILLARD, P.J., VAN DER SANDT I.C.J., VOORWINDEN, L.H., VU, D., NIELSEN, J.L., DE BOER,
A.G., BREIMER, D.D., 2000. Astrocytes increase the functional expression of Pgp in an in
vitro model of the blood-brain barrier. Pharm Res 17: 1198-1205.
GARBERG, P., BALL, M., BORG, N., CECCHELLI, R., FENART, L., HURST, R.D., LINDMARK, T.,
MABONDZO, A., NILSSON, J.E., RAUB, T.J., STANIMIROVIC, D., TERASAKI, T., OBERG,
J.O., OSTERBERG, T., 2005. In vitro models for the blood–brain barrier. Toxicol. In Vitro 19:
299–334.
GARCIA, C.M., DARLAND, D.C., MASSINGHAM, L.J., D’AMORE, P.A., 2004. Endothelial cellastrocyte
interactions and TGF beta are required for induction of blood-neural barrier
properties. Brain Res Dev Brain Res. 152: 25-38.
GARCÍA-MORALES, I., DE LA PEÑA MAYOR, P., KANNER, A.M., 2008. Psychiatric comorbidities in
epilepsy: identification and treatment. Neurologist 14 Suppl 1: 15-25.
GEDEON, C., BEHRAVAN, J., KOREN, G., PIQUETTE-MILLER, M., 2006. Transport of glyburide by
placental ABC transporters: implications in fetal drug exposure. Placenta 27: 1096–102.
GENNUSO, F., FERNETTI, C., TIROLO, C., TESTA, N., L’EPISCOPO, F., CANIGLIA, S., MORALE,
M.C., OSTROW, J.D., PASCOLO, L., TIRIBELLI, C., MARCHETTI, B., 2004. Bilirubin protects
astrocytes from ist own toxicity by inducing up-regulation and translocation of multidrug
resistance-associated protein 1 (Mrp1). Proc Natl Acad Sci USA 101: 2470 –2475.
GERNERT, M., FEDROWITZ, M., WLAZ, P., LÖSCHER, W., 2004. Subregional changes in discharge
rate, pattern, and drug sensitivity of putative GABAergic nigral neurons in the kindling model of
epilepsy. Eur. J. Neurosci. 20: 2377-2386.
GIESSMANN, T., MAY, K., MODESS, C., WEGNER, D., HECKER, U., ZSCHIESCHE, M., DAZERT,
P., GRUBE, M., SCHROEDER, E., WARZOK, R., CASCORBI, I., KROEMER, H.K.,
SIEGMUND, W., 2004. Carbamazepine regulates intestinal P-glycoprotein and multidrug
187